title: Characterization of low pH-induced catecholamine secretion in the rat adrenal medulla.
abstract: Catecholamine (CA) secretion was evoked when the isolated rat adrenal gland was perfused with HEPES-buffered Krebs solution acidified by the addition of HCl or by gassing with 95% O2/5% CO2. The secretion was detectable at pH 7.0 and increased with decreasing pH until at approximately 6.4. The low pH-induced CA secretion consisted of two phases, an initial transient response followed by a sustained phase. An intracellular Ca2+ antagonist, 3,4,5-trimethoxybenzoic acid 8-(N,N-diethylamino)octyl ester, selectively inhibited the initial phase of secretion. Both of the responses were resistant to nifedipine, a blocker of voltage-gated Ca2+ channel, but were completely inhibited in Ca(2+)-free (1 mM EGTA containing) solution. Adrenaline was an exclusive component in CAs released by low pH. The time course and extent of intracellular acidification caused either by low pH in the external medium or by the offset of a transitory NH4Cl application had no correlation with those of the secretory responses in the corresponding period. These results suggest that extracellular acidification preferentially activates adrenaline secretive cells to evoke CA secretion and that this low pH-induced CA secretion may be mediated by dihydropyridine-insensitive Ca2+ influx. Furthermore, the initial transient phase of the low pH-induced CA secretion might be caused by a Ca2+ release from intracellular stores, which is also induced by the Ca2+ influx.
authors.affiliation: Department of Anesthesiology, Niigata University School of Medicine, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Fujiwara
authors.forename: A
authors.initials: A
authors.lastname: Warashina
authors.forename: K
authors.initials: K
authors.lastname: Shimoji
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000313:Adrenal Medulla / Q000187:drug effects / Q000378:metabolism*; D000584:Amiloride / Q000494:pharmacology; D000643:Ammonium Chloride / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism* / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism*; D005452:Fluoresceins; D005456:Fluorescent Dyes; D016257:Fura-2; D006632:Histamine / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D009116:Muscarine / Q000494:pharmacology; D009543:Nifedipine / Q000494:pharmacology; D010477:Perfusion; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
chemical_list: D002395:Catecholamines; D005452:Fluoresceins; D005456:Fluorescent Dyes; D000643:Ammonium Chloride; D000584:Amiloride; D009116:Muscarine; D006632:Histamine; C043829:2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein; D009543:Nifedipine; D000109:Acetylcholine; D011188:Potassium; D001920:Bradykinin; D002118:Calcium; D016257:Fura-2